Cargando…

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer

Purpose: The present study aims to explore the potential mechanisms contributing to prostate cancer (PCa), screen the hub genes, and identify potential biomarkers and correlated pathways of PCa progression. Methods: The PCa gene expression profile GSE3325 was operated to analyze the differentially e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zhengshuai, Huang, Yu, Zhao, Ye, Ruan, Hailong, Yang, Hongmei, Cao, Qi, Liu, Di, Zhang, Xiaoping, Chen, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485223/ https://www.ncbi.nlm.nih.gov/pubmed/31031850 http://dx.doi.org/10.7150/jca.29571

Ejemplares similares

The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma
por: Bao, Lin, et al.
Publicado: (2020)

The screening of pivotal gene expression signatures and biomarkers in renal carcinoma
por: Ruan, Hailong, et al.
Publicado: (2019)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

Long non-coding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma
por: Xiao, Haibing, et al.
Publicado: (2017)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer
por: Miao, Qi, et al.
Publicado: (2023)

Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression
por: Song, Zhengshuai, et al.
Publicado: (2023)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
por: Wang, Keshan, et al.
Publicado: (2018)

Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods
por: He, Zihao, et al.
Publicado: (2019)

LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020)

LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
por: Wang, KeShan, et al.
Publicado: (2019)

Causes of Death Among Prostate Cancer Patients Aged 40 Years and Older in the United States
por: Ye, Yuzhong, et al.
Publicado: (2022)

ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3
por: Zhou, Lijie, et al.
Publicado: (2021)

Identification of potential diagnostic and prognostic biomarkers for prostate cancer
por: Zhang, Qiang, et al.
Publicado: (2019)

Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis
por: Yu, Tingyan, et al.
Publicado: (2022)

Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer
por: Liu, Rui-ji, et al.
Publicado: (2021)

Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Identification of Potential Biomarkers and Biological Pathways in Juvenile Dermatomyositis Based on miRNA-mRNA Network
por: Qiu, Cheng-Cheng, et al.
Publicado: (2019)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Identification of Potential Biomarkers and Biological Pathways for Poor Clinical Outcome in Mucinous Colorectal Adenocarcinoma
por: Kim, Chang Woo, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

Bioinformatics Analysis of Potential Biomarkers and Pathway Identification for Major Depressive Disorder
por: Qi, Dong, et al.
Publicado: (2021)

Identification of plasma hsa_circ_0008673 expression as a potential biomarker and tumor regulator of breast cancer
por: Hu, Youting, et al.
Publicado: (2020)

Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis
por: Liu, Huanqing, et al.
Publicado: (2021)

Identification of Filamin-A and -B as potential biomarkers for prostate cancer
por: Narain, Niven R, et al.
Publicado: (2016)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2019)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2022)

Potentials of single‐cell biology in identification and validation of disease biomarkers
por: Niu, Furong, et al.
Publicado: (2016)

miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma
por: Chen, Xuanyu, et al.
Publicado: (2018)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

Identification of SPOP related metabolic pathways in prostate cancer
por: Yan, Min, et al.
Publicado: (2017)

Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA
por: Ouyang, Shaxi, et al.
Publicado: (2021)

Identification of potential pathways and biomarkers linked to progression in ALS
por: Huber, Roland G., et al.
Publicado: (2022)

Current Progress for Retrospective Identification of Nerve Agent Biomarkers in Biological Samples after Exposure
por: Wang, Jin, et al.
Publicado: (2022)

Identification, Biological Activities and Biosynthetic Pathway of Dendrobium Alkaloids
por: Mou, Zongmin, et al.
Publicado: (2021)

Citric Acid as a Potential Prostate Cancer Biomarker Determined in Various Biological Samples
por: Buszewska-Forajta, Magdalena, et al.
Publicado: (2022)

Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression
por: Zhang, Jinpeng, et al.
Publicado: (2022)

Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
por: Sun, Chuanyu, et al.
Publicado: (2011)

Screening and identification of key biomarkers in prostate cancer using bioinformatics
por: Li, Song, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qmipoht4q6v06q4r5njepiehtn